Prosonix Elects Dr Ken Cunningham as Non-executive Chairman
Dr Cunningham was elected to the Board of Prosonix as a Non-executive Director in September 2011, and is also Chair of Prosonix’s Scientific Advisory Board. He has over 20 years' experience in the pharmaceutical industry with a strong focus in recent years on respiratory drug development and drug delivery. He is Chairman of PolyTherics Ltd and until August 2010 was CEO of Skyepharma plc. Before that he was Chief Executive Officer of Arakis Ltd, Vice-President European Affairs at Alza Corporation and Vice-President Clinical Development at Sequus Inc. He holds a medical degree from St Mary's, Imperial College, London University.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.